These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

831 related items for PubMed ID: 28576247

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Management of ocular conditions in the burn unit: thermal and chemical burns and Stevens-Johnson syndrome/toxic epidermal necrolysis.
    Lin A, Patel N, Yoo D, DeMartelaere S, Bouchard C.
    J Burn Care Res; 2011; 32(5):547-60. PubMed ID: 21799437
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Stevens-Johnson Syndrome: A Challenging Diagnosis.
    Davis WD, Schafer PA.
    Adv Emerg Nurs J; 2018; 40(3):176-182. PubMed ID: 30059372
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Life-threatening Skin Disorders Treated in the Burn Center: Impact of Health care-associated Infections on Length of Stay, Survival, and Hospital Charges.
    Hermiz SJ, Diegidio P, Ortiz-Pujols S, Garimella R, Weber DJ, van Duin D, Hultman CS.
    Clin Plast Surg; 2017 Jul; 44(3):597-602. PubMed ID: 28576248
    [Abstract] [Full Text] [Related]

  • 9. Improving mortality outcomes of Stevens Johnson syndrome/toxic epidermal necrolysis: A regional burns centre experience.
    Nizamoglu M, Ward JA, Frew Q, Gerrish H, Martin N, Shaw A, Barnes D, Shelly O, Philp B, El-Muttardi N, Dziewulski P.
    Burns; 2018 May; 44(3):603-611. PubMed ID: 29029855
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A decade of burn unit experience with Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: Clinical pathological diagnosis and risk factor awareness.
    Lim VM, Do A, Berger TG, Nguyen AH, DeWeese J, Malone JD, Jordan K, Hom F, Tuffanelli L, Fillari P, Siu S, Grossman R.
    Burns; 2016 Jun; 42(4):836-43. PubMed ID: 26847613
    [Abstract] [Full Text] [Related]

  • 18. An approach to the management of toxic epidermal necrolysis in a burn centre.
    Green D, Law E, Still JM.
    Burns; 1993 Oct; 19(5):411-4. PubMed ID: 8216769
    [Abstract] [Full Text] [Related]

  • 19. [News in severe clinical adverse drug reactions: Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN)].
    Martínez-Cabriales SA, Gómez-Flores M, Ocampo-Candiani J.
    Gac Med Mex; 2015 Oct; 151(6):777-87. PubMed ID: 26581536
    [Abstract] [Full Text] [Related]

  • 20. Outcomes in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Patients Treated With a Medicine-Led Multidisciplinary Approach.
    Lewcun JA, Vagonis A, Kontzias C, Newsom M, Drake M, Feldman MJ.
    J Burn Care Res; 2024 Jan 05; 45(1):165-168. PubMed ID: 37698266
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.